-+ 0.00%
-+ 0.00%
-+ 0.00%

China Sanjiang Fine Chemicals (SEHK:2198) Stock Trades On 5.1x As Profit Jumps

Simply Wall St·08/27/2026 12:25:01
Listen to the news

China Sanjiang Fine Chemicals closed at HK$3.865 on Thursday, capping a strong 30-day run. Yet the real story sits in the fresh H1 2026 earnings. Revenue reached C¥9,599.5m and basic earnings per share came in at C¥0.5686, which puts the stock on a trailing P/E of 5.1x, well below both the wider Hong Kong market and chemicals peers.

That gap between a low earnings multiple and solid trailing profit growth is the tension investors now need to focus on. The short term share price strength is only the opening act for a deeper valuation debate.

Is China Sanjiang Fine Chemicals a genuine bargain on 5.1x trailing P/E, or is the low multiple the market’s way of flagging risk around cash flow and debt coverage? Compare the current price against our detailed valuation analysis for China Sanjiang Fine Chemicals

H1 2026 Earnings Summary

  • Revenue H1 2026 vs. H1 2025: C¥9,599.5m vs. C¥9,105.7m (higher period on period)
  • Net Income H1 2026 vs. H1 2025: C¥656.1m vs. C¥301.1m (higher period on period)
  • Basic EPS H1 2026 vs. H1 2025: C¥0.5686 vs. C¥0.2601 (higher period on period)
  • Trailing Net Profit Margin (last 12 months): 4% vs. 3.5% a year earlier (margin improved year on year)

Prefer clean visuals instead of another wall of financial tables and text? View China Sanjiang Fine Chemicals’ full financial picture, including a clear valuation snapshot, in our company report for China Sanjiang Fine Chemicals.

SEHK:2198 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
SEHK:2198 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

China Sanjiang Fine Chemicals: Signals Supporting Optimism

For a bullish view on China Sanjiang Fine Chemicals, the earnings trend gives some support. Revenue for H1 2026 is higher than H1 2025 and net income is also higher period on period. Basic EPS has risen over the same comparison. The trailing net profit margin of 4% compares with 3.5% a year earlier, so profitability has moved in a supportive direction. Combined with strong 30 day and 90 day share price gains, the latest numbers align with a more constructive read on the business.

China Sanjiang Fine Chemicals: Risks Still On The Radar

There is also plenty for cautious investors to watch with China Sanjiang Fine Chemicals. A trailing net margin of 4% remains modest for a chemicals producer, which leaves less room to absorb any future cost pressure or weaker demand. The recent share price run, including a 31% move over 30 days and 14% over 90 days, indicates that expectations have reset quickly. If earnings momentum slows from this point, that move could amplify worries about how durable the current profitability trend is.

After a 31% 30 day surge and a relatively modest 4% margin, volatility and leverage can quickly matter. Review our independent risk analysis for China Sanjiang Fine Chemicals which shows 2 important warning signs.

Stay Ahead Of Your Next Move

China Sanjiang Fine Chemicals has just posted fresh H1 2026 numbers and a low trailing P/E, which makes timing and valuation checks even more important. Register for free with Simply Wall St and add China Sanjiang Fine Chemicals to your Watchlist to track its share price against fair value and watch how the story develops. When you decide to build or adjust a position, use the Portfolio Command Center to cut through noise and stay on top of the updates that matter for your holdings. Over the long run, you can lean on the Community to see how other investors are thinking, uncover potential catalysts or risks early, and stay a step ahead of the market.

Seeking Alternatives Beyond China Sanjiang Fine Chemicals

Fresh stock ideas can move from quiet accumulation to breakout momentum quickly. Scan these curated picks before the crowd catches on and the best entry points drop away.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.